Product data
Form, amount, storage and other technical data come from verified supplier or manufacturer documentation. Missing information remains marked as pending.
Research & Testing Policy
Separate verifiable data from context.
This policy explains where AXIOM obtains product information, studies, regulatory information and laboratory values, and how those data are published.
Last reviewed: 2 Oct 2026Batch analytics
Identity, amount, purity and other laboratory values are copied only from the specific batch report. Peptide laboratory testing is performed by Janoshik.
Scientific literature
Studies are preferably linked through PubMed or the original publication. Study results are presented as research context rather than product properties.
Regulatory status
Approval and development status is derived from official authority, sponsor or manufacturer sources and dated when time-sensitive.
Research vs medicinal product
Information about an active ingredient or approved finished medicinal product is not automatically transferred to an AXIOM research vial.
Corrections & updates
When a source, specification or regulatory status changes, affected content is updated rather than retaining outdated claims for convenience.
External analytics
Janoshik
Janoshik offers peptide analysis, including a common blind test for Semaglutide, Tirzepatide and Retatrutide. AXIOM publishes real results only for the batch that was actually tested.
Janoshik peptide services ↗Method quality
ICH Q2(R2)
For interpretation of analytical procedures, the research documentation uses established concepts such as specificity, accuracy, precision, detection and quantitation limits, linearity and range.
EMA / ICH Q2(R2) ↗No invented gap filling
If purity, storage conditions, shelf life, certification or another technical value has not been verified, it is not copied from competitors, similar products or generic assumptions. It remains pending until reliable evidence exists.